Ono Pharmaceutical Co. Ltd (OPHLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 391,565 | 1,129,765 | 1,062,137 | 934,723 | 948,366 |
| Depreciation Amortization | 177,500 | 125,166 | 129,137 | 157,717 | 148,708 |
| Accounts receivable | 48,781 | -136,496 | -107,396 | -136,019 | -67,483 |
| Accounts payable and accrued liabilities | 137,999 | -12,662 | 96,866 | 72,775 | 59,793 |
| Other Working Capital | 253,024 | -199,810 | 10,634 | -267,952 | -61,241 |
| Other Operating Activity | -464,640 | -142,410 | -10,264 | -210,966 | -332,760 |
| Operating Cash Flow | $544,229 | $763,554 | $1,181,114 | $550,278 | $695,384 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,342,961 | 609,491 | 355,170 | 496,620 | 289,520 |
| PPE Investments | -35,785 | -21,507 | -39,472 | -48,799 | -65,950 |
| Net Acquisitions | -2,407,786 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -18,863 | -23,453 | -17,997 | -10,030 | -7,144 |
| Sale Of Investment | 246,576 | 122,054 | 58,194 | 202,760 | 131,910 |
| Purchase Sale Intangibles | -16,889 | -115,982 | -67,762 | -60,342 | -124,785 |
| Other Investing Activity | -29,884 | -354,853 | -1,097,812 | -586,813 | -889,644 |
| Investing Cash Flow | $-902,781 | $331,731 | $-741,917 | $53,738 | $-541,308 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 990,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | -99,000 | N/A | N/A | N/A | N/A |
| Dividend Paid | -247,678 | -256,625 | -220,135 | -246,263 | -211,077 |
| Other Financing Activity | -20,948 | -363,326 | -20,246 | -289,846 | -21,611 |
| Financing Cash Flow | $622,373 | $-619,951 | $-240,382 | $-536,109 | $-232,688 |
| Exchange Rate Effect | -10,217 | 7,700 | 1,147 | 3,880 | 3,788 |
| Beginning Cash Position | 1,096,531 | 663,332 | 511,429 | 543,301 | 648,647 |
| End Cash Position | 1,350,142 | 1,146,373 | 711,399 | 615,097 | 573,823 |
| Net Cash Flow | $253,612 | $483,041 | $199,970 | $71,796 | $-74,824 |
| Free Cash Flow | |||||
| Operating Cash Flow | 544,229 | 763,554 | 1,181,114 | 550,278 | 695,384 |
| Capital Expenditure | -35,845 | -27,738 | -39,516 | -48,923 | -65,969 |
| Free Cash Flow | 508,385 | 735,816 | 1,141,598 | 501,355 | 629,415 |